, Malaysia

Allianz Malaysia posts 7.3% hike in H1 2020 gross written premiums

Both its life and general insurance arms also recorded GWP growths.

Allianz Malaysia recorded a 7.3% hike in gross written premiums (GWP) to $613.6m (MYR2.56b) in H1 2020, with total assets growing 8.9% to $4.9b (MYR20.51b), according to an announcement.

Profit before tax improved 3.5% to $81.6m (MYR350.4m) compared to $78.8m (MYR329m) posted in H1 2019.

Its general insurance arm Allianz General registered a 6.3% growth in GWP to $273m (MYR1.14b) from $256m (MYR1.07b) a year ago. Underwriting results rose 17% to $23.5 (MYR98.3m) on the back of lower motor claims during the movement control order (MCO) period, whilst profit before tax inched up 9.4 percent to $46.5m (MYR193.9m).

Allianz General’s combined ratio stood at 90.1%. It captured a 12.9% market share in Q1 this year, the insurer claimed, citing the ISM Insurance Services Malaysia Berhad (ISM) market performance study.

Allianz Life also saw an 8.2% jump in GWP to $340m (MYR1.42b) in the first half of 2020, but annualised new premiums (ANP) shrank 25.2% to $51.1m (MYR213.4m). Profit before tax also contracted 1.6% dip to $37.1m (MYR155.1m) from $37.8m (MYR157.6m) a year ago.

Based on Life Insurance Association of Malaysia (LIAM) statistics for January to June, Allianz Life captured an 8% market share, the insurer said.
 

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.